AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Skye Bioscience, Inc. Director's Dealing 2018

Oct 12, 2018

34097_dirs_2018-10-12_afc7f15b-0f10-48b8-aa14-7f4286f260a2.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2018-10-05

Reporting Person: DHILLON AVTAR S (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct